Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Alan Meds vs OnlyRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.7

Alan Meds

Best for budget-conscious shoppers
★★★3.9

Starting at $99/mo

CompoundedSemaglutideTirzepatideOral Format
Visit Alan Meds
6.4

OnlyRx

Best for Buyers comparing cash-pay compounded-GLP-1 platforms who want oral-tablet form factors (ODT) alongside the standard subcutaneous injection, value the transparency of named prescribers + named pharmacy partners, and accept a four-pharmacy fulfillment model rather than a single named compounder.
★★★☆☆3.2

Starting at $179/mo

Compounded Semaglutide (injection + ODT)Compounded Tirzepatide (injection + ODT)Branded Ozempic/Wegovy/Zepbound/Mounjaro Available4 Named Physicians (MD/DO)
Visit OnlyRx

Side-by-Side Comparison

FeatureAlan MedsOnlyRx
Overall Score7.7/106.4/10
Starting Price$99/mo$179/mo
Editorial Rating3.9 ★ /53.2 ★ /5
Features5 features10 features
States Available460
Compounded✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Alan Meds

Pros

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access
  • Multiple administration formats

Cons

  • Limited public information on program details

OnlyRx

Pros

  • Four-pharmacy fulfillment network (Belmar, Strive, Epiq Scripts, Casa Pharma RX) — three of four are already in our pharmacy registry with independent verification
  • Named prescriber roster on the public site (Dr. Carr MD, Dr. Tenbrink MD, Dr. Italia MD, Dr. Mansour DO) — stronger transparency than peers with anonymous clinical networks
  • ODT (oral disintegrating tablet) compounded form for both semaglutide and tirzepatide — uncommon offering that fits needle-averse patients
  • Server-side rendered Nuxt site (not a SPA blank shell) — pricing, drug list, pharmacy partners, and physician roster all extractable from the static HTML, reducing the YMYL opacity penalty most newer entrants take
  • LegitScript Certified claim on the public site
  • Branded Ozempic/Wegovy/Zepbound/Mounjaro available alongside the compounded line — patients can step up to FDA-approved branded products without switching platforms

Cons

  • Promo pricing ($179 semaglutide injection floor) is marketed prominently; the post-promo maintenance dose pricing is not surfaced on the static site
  • No specific titration ladder pricing — buyers can't see what they'll pay at 1.0 mg or 2.4 mg semaglutide maintenance
  • Refund / cancellation policy not stated on the homepage
  • Lab-work requirement not stated — most legitimate GLP-1 telehealth platforms require baseline labs or a recent metabolic panel
  • LegitScript merchant-ID independent lookup at safe.legitscript.com NOT verified this cycle (claim is on the site but independent confirmation pending)
  • Operating corporate entity not disclosed in the static HTML — the platform self-describes as connecting patients to independent licensed providers but does not name the operating LLC or corporation
  • Epiq Scripts is the one named pharmacy partner not yet independently verified in our pharmacy registry

Our Verdict

Winner: Alan MedsScore: 7.7/10

Alan Meds edges out OnlyRx with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. OnlyRx remains a solid alternative, especially if you're looking for Buyers comparing cash-pay compounded-GLP-1 platforms who want oral-tablet form factors (ODT) alongside the standard subcutaneous injection, value the transparency of named prescribers + named pharmacy partners, and accept a four-pharmacy fulfillment model rather than a single named compounder..

Glossary references

Key terms in this article, linked to their canonical definitions.

Related comparisons

Continue exploring Alan Meds and OnlyRx head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.